An antibody for eligible prurigo nodularis or atopic dermatitis.
Profile scope: Nemolizumab-ilto injection. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Headache, muscle discomfort, or joint discomfort may occur.
Serious risks and warning signs
Severe allergy can include rash, swelling, wheezing, faintness, swollen glands, or fever and requires prompt help. Significant digestive symptoms associated with a reaction also need advice. Follow product-specific vaccination and administration instructions.
A question for your healthcare team
What reaction-response and vaccine plan applies, and which symptoms should prevent another dose pending advice?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.